NCT05504135View on ClinicalTrials.gov

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

CompletedOBSERVATIONAL

Enrollment

222

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2024

Conditions

Pre-emptive Pharmacogenomics

Interventions

DIAGNOSTIC_TEST

Pharmacogenomics Testing

To test if pharmacogenomics information (produced from testing) included by us in the Raffles' Electronic Health Records (EHR) will be used by physicians to personalize patients' prescriptions.

Trial Locations (1)

188770

Raffles Hospital, Singapore

All Listed Sponsors

lead

Nalagenetics Pte Ltd

INDUSTRY